EMD-62629

Single-particle
2.71 Å
EMD-62629
3D View Gallery
Deposition: 07/12/2024
Map released: 10/12/2025
Last modified: 10/12/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-62629
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 9kxv summary report (pdf.gz) Map and 9kxv FULL report (pdf.gz)
EMICSS annotations (xml)

Structure of human B0AT1-ACE2 complex with compound3

EMD-62629

Single-particle
2.71 Å
EMD-62629
3D View Gallery
Deposition: 07/12/2024
Map released: 10/12/2025
Last modified: 10/12/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens
Sample: Ternary complex of B0AT1, ACE2 and inhibitor
Fitted models: 9kxv

Deposition Authors: Imazu T, Miyaguchi I, Hiraizumi M

Structure-guided development of a potent human B0AT1 inhibitor effective in a mouse model of phenylketonuria
Imazu T, Akashi T, Hiraizumi M, Inui Y, Sasaki W, Takahashi T, Todoroki H, Kumanomidou T, Hisano H, Asada H, Kusakizako T, Nishizawa T, Iwata S, Nureki O, Miyaguchi I
To Be Published
Grant Support: